MYL4 and atrial fibrillation: As reported in a recent study, the Cx43 hemichannel blockade was screened as a potent inhibitor for the abnormal phenotypes in both hESC-atrial cells in vitro model and zebrafish in vivo model of MYL4 (myosin light chain 4) mutation related AF [103].